These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1030 related articles for article (PubMed ID: 12382069)

  • 21. Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G-protein-coupled receptor.
    Ramsay D; Bevan N; Rees S; Milligan G
    Br J Pharmacol; 2001 May; 133(2):315-23. PubMed ID: 11350868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the DRY motif and the missing "ionic lock" on constitutive activity and G-protein coupling of the human histamine H4 receptor.
    Schneider EH; Schnell D; Strasser A; Dove S; Seifert R
    J Pharmacol Exp Ther; 2010 May; 333(2):382-92. PubMed ID: 20106995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The G protein-coupled receptor repertoires of human and mouse.
    Vassilatis DK; Hohmann JG; Zeng H; Li F; Ranchalis JE; Mortrud MT; Brown A; Rodriguez SS; Weller JR; Wright AC; Bergmann JE; Gaitanaris GA
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4903-8. PubMed ID: 12679517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy as a vector: the relative prevalence and paucity of inverse agonism.
    Kenakin T
    Mol Pharmacol; 2004 Jan; 65(1):2-11. PubMed ID: 14722230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible translocation of p115-RhoGEF by G(12/13)-coupled receptors.
    Meyer BH; Freuler F; Guerini D; Siehler S
    J Cell Biochem; 2008 Aug; 104(5):1660-70. PubMed ID: 18320579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inverse agonism: more than reverting constitutively active receptor signaling.
    Dupré DJ; Rola-Pleszczynski M; Stanková J
    Biochem Cell Biol; 2004 Dec; 82(6):676-80. PubMed ID: 15674435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role and modulation of G protein-coupled receptor signaling in inflammatory processes.
    Lombardi MS; Kavelaars A; Heijnen CJ
    Crit Rev Immunol; 2002; 22(2):141-63. PubMed ID: 12433131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylation-independent desensitization of G protein-coupled receptors?
    Pao CS; Benovic JL
    Sci STKE; 2002 Oct; 2002(153):pe42. PubMed ID: 12372852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal growth factor differentially augments G(i)-mediated stimulation of c-Jun N-terminal kinase activity.
    Chan AS; Wong YH
    Br J Pharmacol; 2004 Jun; 142(4):635-46. PubMed ID: 15172963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A constitutively active GPCR retains its G protein specificity and the ability to form dimers.
    Ladds G; Davis K; Das A; Davey J
    Mol Microbiol; 2005 Jan; 55(2):482-97. PubMed ID: 15659165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G-protein-coupled receptors: an update.
    Fredholm BB; Hökfelt T; Milligan G
    Acta Physiol (Oxf); 2007 May; 190(1):3-7. PubMed ID: 17428227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statistical analysis and prediction of functional residues effective for GPCR-G-protein coupling selectivity.
    Muramatsu T; Suwa M
    Protein Eng Des Sel; 2006 Jun; 19(6):277-83. PubMed ID: 16565146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylation-independent attenuation of GPCR signalling.
    Ferguson SS
    Trends Pharmacol Sci; 2007 Apr; 28(4):173-9. PubMed ID: 17350109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor.
    Alewijnse AE; Timmerman H; Jacobs EH; Smit MJ; Roovers E; Cotecchia S; Leurs R
    Mol Pharmacol; 2000 May; 57(5):890-8. PubMed ID: 10779371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When a G protein-coupled receptor does not couple to a G protein.
    Sun Y; McGarrigle D; Huang XY
    Mol Biosyst; 2007 Dec; 3(12):849-54. PubMed ID: 18000562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
    Bodenstein J; Venter DP; Brink CB
    J Pharmacol Exp Ther; 2005 Aug; 314(2):891-905. PubMed ID: 15857948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inverse agonist activity of selected ligands of platelet-activating factor receptor.
    Dupré DJ; Le Gouill C; Rola-Pleszczynski M; Stanková J
    J Pharmacol Exp Ther; 2001 Oct; 299(1):358-65. PubMed ID: 11561099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constitutive activity and ligand selectivity of human, guinea pig, rat, and canine histamine H2 receptors.
    Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2007 Jun; 321(3):983-95. PubMed ID: 17332265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the extracellular amino terminus and first membrane-spanning helix of dopamine D1 and D5 receptors in shaping ligand selectivity and efficacy.
    D'Aoust JP; Tiberi M
    Cell Signal; 2010 Jan; 22(1):106-16. PubMed ID: 19786093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constitutive activity of human angiotensin II type-1 receptors by Gq overexpression.
    Scragg JL; Warburton P; Ball SG; Balmforth AJ
    Biochem Biophys Res Commun; 2005 Aug; 334(1):134-9. PubMed ID: 15992776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.